Health Products

BD BBL Sensi Disc Ampicillin 2 Μg (AM-2)

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - Microbiology
Product: BD BBL Sensi Disc Ampicillin 2 Μg (AM-2)
Issue: Medical devices - Performance
What to do: Contact the manufacturer if you require additional information.
Audience: Industry
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Affected productsLot or serial numberModel or catalog number
BD BBL Sensi Disc Ampicillin 2 Μg (AM-2)3234190
3184064
2339360
3010977
231263

Issue

BD identified through potency test, as part of special stability test requests to monitor Ampicillin AM-2, unsatisfactory results of 65% at 18 months. The potency acceptance criteria is 80-140% and product shelf life is 24 months. A retest with control batch and extended sampling confirmed the low potency results.

Recall Start Date: November 6, 2024

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime